Home Visit
Upload
CLL Prognostication/Risk Stratification Gene Panel - EDTA Whole Blood
50+ booked in last 3 days
No special precautions
Sample Type
Blood
Recommended for
Male, Female
Report
Within 24 Hours
Blood test at Home
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
Overview
The CLL (Chronic Lymphocytic Leukemia) prognostication/risk stratification gene panel, performed on EDTA whole blood samples, is a diagnostic test used for assessing the prognosis and risk stratification of patients with CLL. This gene panel examines various genetic markers and mutations associated with CLL like TP53, NOTCH1, SF3B1, ATM, and other relevant genes. By analyzing these genetic markers, the panel helps in predicting disease progression, treatment response, and overall patient outcomes. The results of the panel aid healthcare professionals in determining the appropriate management strategies, including the selection of therapies and the frequency of follow-up evaluations. This CLL prognostication gene panel serves as a valuable tool in tailoring individualized treatment approaches and improving patient care for those diagnosed with CLL.
CLL Prognostication/Risk Stratification Gene Panel - EDTA Whole Blood Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the CLL Prognostication/Risk Stratification Gene Panel - EDTA Whole Blood with a clear pricing structure.
The CLL Prognostication/Risk Stratification Gene Panel - EDTA Whole Blood Price in Mumbai is ₹ 17,850 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
CLL Prognostication Gene Panel analyzes specific genes associated with CLL that helps in predicting disease progression, treatment response, and overall patient outcomes.
• To assess the risk stratification and prognosis of CLL • To guide treatment decisions by identifying high-risk patients who may require more aggressive therapies • To determine eligibility for clinical trials or targeted therapies based on specific gene mutations
CLL Prognostication Gene Panel is recommended for individuals with • newly diagnosed CLL to evaluate risk stratification and determine appropriate treatment plans, • recurring or persistent CLL to assess disease progression and guide further therapeutic interventions, or • high-risk features such as unexplained cytopenias or rapid lymphocyte doubling time.
If the results of the CLL Prognostication Gene Panel show abnormalities, it may indicate a higher-risk profile for CLL. Abnormalities in specific genes can suggest a more aggressive disease course and may influence treatment decisions.
During the test, a small sample of whole blood or bone marrow aspirate will be collected. The sample will be sent to a laboratory for Next-Generation Sequencing (NGS) analysis.
• Fill out the genetic history form. • Follow any dietary or medication restrictions provided by your doctor. • Provide any relevant medical reports or imaging studies related to CLL or other related conditions. • Inform your doctor if you have any specific requirements.
• Complete Blood Count (CBC): To assess blood cell counts and evaluate the extent of bone marrow involvement • Flow Cytometry: To determine the immunophenotypic profile of CLL cells • Cytogenetic Analysis: To identify chromosomal abnormalities associated with CLL
Chronic Lymphocytic Leukaemia Genetic Testing
Chronic Lymphocytic Leukaemia is a cancer affecting white blood cells. It is characterised by uncontrolled growth and accumulation of abnormal lymphocytes in the blood, bone marrow, and lymph nodes.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
WhatsApp